advertisement
Sakata R 8
Showing records 1 to 8 | Display all abstracts from Sakata R94535 The Additive Effect of ROCK Inhibitor on Prostaglandin-Treated Japanese Patients with Glaucoma Indicating 15 mmHg and Under: ROCK U-15
Sakata R
Advances in Therapy 2021; 38: 3760-3770
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Sakata R; Fujishiro T
Japanese Journal of Ophthalmology 2021; 65: 591-597
94535 The Additive Effect of ROCK Inhibitor on Prostaglandin-Treated Japanese Patients with Glaucoma Indicating 15 mmHg and Under: ROCK U-15
Fujishiro T; Saito H
Advances in Therapy 2021; 38: 3760-3770
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Saito H
Japanese Journal of Ophthalmology 2021; 65: 591-597
94535 The Additive Effect of ROCK Inhibitor on Prostaglandin-Treated Japanese Patients with Glaucoma Indicating 15 mmHg and Under: ROCK U-15
Honjo M
Advances in Therapy 2021; 38: 3760-3770
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Nakamura N; Honjo M
Japanese Journal of Ophthalmology 2021; 65: 591-597
94535 The Additive Effect of ROCK Inhibitor on Prostaglandin-Treated Japanese Patients with Glaucoma Indicating 15 mmHg and Under: ROCK U-15
Shirato S; Aihara M
Advances in Therapy 2021; 38: 3760-3770
94608 Recovery of deepening of the upper eyelid sulcus after switching from prostaglandin FP receptor agonists to EP2 receptor agonist: a 3-month prospective analysis
Shirato S; Miyamoto E; Yamada Y; Aihara M
Japanese Journal of Ophthalmology 2021; 65: 591-597
